a b s t r a c t VGF (nonacronymic) is a granin-like protein that is packaged and proteolytically processed within the regulated secretory pathway. VGF and peptides derived from its processing have been implicated in neuroplasticity associated with learning, memory, depression, and chronic pain. In sensory neurons, VGF is rapidly increased following peripheral nerve injury and inflammation. Several bioactive peptides generated from the C-terminus of VGF have pronociceptive spinal effects. The goal of the present study was to examine the spinal effects of the peptide TLQP-21 and determine whether it participates in spinal mechanisms of persistent pain. Application of exogenous TLQP-21 induced dose-dependent thermal hyperalgesia in the warm-water immersion tail-withdrawal test. This hyperalgesia was inhibited by a p38 mitogen-activated protein kinase inhibitor, as well as inhibitors of cyclooxygenase and lipoxygenase. We used immunoneutralization of TLQP-21 to determine the function of the endogenous peptide in mechanisms underlying persistent pain. In mice injected intradermally with complete Freund adjuvant, intrathecal treatment with anti-TLQP-21 immediately prior to or 5 hours after induction of inflammation dose-dependently inhibited tactile hypersensitivity and thermal hyperalgesia. Intrathecal anti-TL21 administration also attenuated the development and maintenance of tactile hypersensitivity in the spared nerve injury model of neuropathic pain. These results provide evidence that endogenous TLQP-21 peptide contributes to the mechanisms of spinal neuroplasticity after inflammation and nerve injury. Ó
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Introduction
VGF (non-acronymic) is a granin-like neuropeptide precursor whose expression is robustly regulated by neuronal lesions and growth factors [5, 15, 26] . VGF and peptides derived from its proteolytic processing have been implicated in the control of energy balance and metabolism, as well as in neuroplasticity associated with learning, memory, depression, and chronic pain [9, 19, 20, 22, 28, 35, 43] .
Peptides containing the C-terminus of VGF (Fig. 1) potentiate neural activity in cultured hippocampal neurons (ie, TLQP-62 and AQEE-30 [1]), hippocampal slices (ie, TLQP-62 [9]), and dorsal horn neurons (ie, ). Furthermore, intrathecal administration of C-terminal VGF peptides results in thermal hyperalgesia (ie, [35] ) as well as mechanical and cold hypersensitivity (ie, ). VGF is expressed in sensory neurons as well as spinal dorsal horn neurons, and is rapidly upregulated following peripheral inflammation and nerve injury [28, 35] . The significance of VGF as a contributor to chronic pain is highlighted by a metaanalysis of 20 independent microarray studies of neuropathic and inflammatory pain models [25] . Out of 2254 genes considered, VGF was among 7 found to be upregulated in more than one-third of the 20 studies. Of those 7 genes, VGF was 1 of 3 (along with 
